Cargando…
Hydrogen sulfide as a vasculoprotective factor
Hydrogen sulfide is a novel mediator with the unique properties of a gasotransmitter and many and varied physiological effects. Included in these effects are a number of cardiovascular effects that are proving beneficial to vascular health. Specifically, H(2)S can elicit vasorelaxation, prevention o...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648378/ https://www.ncbi.nlm.nih.gov/pubmed/23628084 http://dx.doi.org/10.1186/2045-9912-3-9 |
_version_ | 1782268830352932864 |
---|---|
author | Streeter, Eloise Ng, Hooi H Hart, Joanne L |
author_facet | Streeter, Eloise Ng, Hooi H Hart, Joanne L |
author_sort | Streeter, Eloise |
collection | PubMed |
description | Hydrogen sulfide is a novel mediator with the unique properties of a gasotransmitter and many and varied physiological effects. Included in these effects are a number of cardiovascular effects that are proving beneficial to vascular health. Specifically, H(2)S can elicit vasorelaxation, prevention of inflammation and leukocyte adhesion, anti-proliferative effects and anti-thrombotic effects. Additionally, H(2)S is a chemical reductant and nucleophile that is capable of inhibiting the production of reactive oxygen species, scavenging and neutralising reactive oxygen species and boosting the efficacy of endogenous anti-oxidant molecules. These result in resistance to oxidative stress, protection of vascular endothelial function and maintenance of blood flow and organ perfusion. H(2)S has been shown to be protective in hypertension, atherosclerosis and under conditions of vascular oxidative stress, and deficiency of endogenous H(2)S production is linked to cardiovascular disease states. Taken together, these effects suggest that H(2)S has a physiological role as a vasculoprotective factor and that exogenous H(2)S donors may be useful therapeutic agents. This review article will discuss the vascular effects and anti-oxidant properties of H(2)S as well as examine the protective role of H(2)S in some important vascular disease states. |
format | Online Article Text |
id | pubmed-3648378 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-36483782013-05-09 Hydrogen sulfide as a vasculoprotective factor Streeter, Eloise Ng, Hooi H Hart, Joanne L Med Gas Res Review Hydrogen sulfide is a novel mediator with the unique properties of a gasotransmitter and many and varied physiological effects. Included in these effects are a number of cardiovascular effects that are proving beneficial to vascular health. Specifically, H(2)S can elicit vasorelaxation, prevention of inflammation and leukocyte adhesion, anti-proliferative effects and anti-thrombotic effects. Additionally, H(2)S is a chemical reductant and nucleophile that is capable of inhibiting the production of reactive oxygen species, scavenging and neutralising reactive oxygen species and boosting the efficacy of endogenous anti-oxidant molecules. These result in resistance to oxidative stress, protection of vascular endothelial function and maintenance of blood flow and organ perfusion. H(2)S has been shown to be protective in hypertension, atherosclerosis and under conditions of vascular oxidative stress, and deficiency of endogenous H(2)S production is linked to cardiovascular disease states. Taken together, these effects suggest that H(2)S has a physiological role as a vasculoprotective factor and that exogenous H(2)S donors may be useful therapeutic agents. This review article will discuss the vascular effects and anti-oxidant properties of H(2)S as well as examine the protective role of H(2)S in some important vascular disease states. BioMed Central 2013-04-29 /pmc/articles/PMC3648378/ /pubmed/23628084 http://dx.doi.org/10.1186/2045-9912-3-9 Text en Copyright © 2013 Streeter et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Streeter, Eloise Ng, Hooi H Hart, Joanne L Hydrogen sulfide as a vasculoprotective factor |
title | Hydrogen sulfide as a vasculoprotective factor |
title_full | Hydrogen sulfide as a vasculoprotective factor |
title_fullStr | Hydrogen sulfide as a vasculoprotective factor |
title_full_unstemmed | Hydrogen sulfide as a vasculoprotective factor |
title_short | Hydrogen sulfide as a vasculoprotective factor |
title_sort | hydrogen sulfide as a vasculoprotective factor |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648378/ https://www.ncbi.nlm.nih.gov/pubmed/23628084 http://dx.doi.org/10.1186/2045-9912-3-9 |
work_keys_str_mv | AT streetereloise hydrogensulfideasavasculoprotectivefactor AT nghooih hydrogensulfideasavasculoprotectivefactor AT hartjoannel hydrogensulfideasavasculoprotectivefactor |